• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘露糖结合凝集素的血浆水平与静脉血栓栓塞的未来风险。

Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.

机构信息

K. G. Jebsen - Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Tromsø - The Arctic University of Norway, Tromsø, Norway.

Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

出版信息

J Thromb Haemost. 2019 Oct;17(10):1661-1669. doi: 10.1111/jth.14539. Epub 2019 Jul 1.

DOI:10.1111/jth.14539
PMID:31220397
Abstract

BACKGROUND

Animal and observational studies have suggested a pathophysiological role for complement in venous thromboembolism (VTE), but the initiating mechanisms are unknown. Mannose-binding lectin (MBL) bound to altered host cells leads to activation of the lectin complement pathway, and both high and low MBL levels have been implicated in the pathophysiology of cardiovascular disease.

OBJECTIVES

To investigate the association between plasma MBL levels and future risk of incident VTE.

METHODS

We conducted a nested case-control study in 417 VTE patients and 849 age-matched and sex-matched controls derived from the general population (Tromsø Study). Plasma MBL levels were measured using enzyme-linked immunosorbent assay. Logistic regression models were used to estimate odds ratio (OR) for VTE across quartiles of plasma MBL levels.

RESULTS

Subjects with plasma MBL levels in the lowest quartile (<435 ng/mL) had a reduced OR for overall VTE (OR 0.79, 95% confidence interval [CI]: 0.56-1.10) and for DVT (OR 0.70, 95% CI: 0.47-1.04) compared to those with MBL in the highest quartile (≥2423 ng/mL) after multivariable adjustments. For VTE, DVT, and pulmonary embolism (PE) the ORs decreased substantially with decreasing time between blood sampling and VTE event.

CONCLUSIONS

Our findings suggest that low plasma MBL levels are associated with reduced risk of VTE, and DVT in particular.

摘要

背景

动物和观察性研究表明,补体在静脉血栓栓塞症(VTE)中具有病理生理学作用,但启动机制尚不清楚。与改变的宿主细胞结合的甘露糖结合凝集素(MBL)导致凝集素补体途径的激活,并且高和低 MBL 水平都与心血管疾病的病理生理学有关。

目的

研究血浆 MBL 水平与未来发生 VTE 的风险之间的关联。

方法

我们在来自普通人群(特罗姆瑟研究)的 417 例 VTE 患者和 849 例年龄和性别匹配的对照者中进行了一项嵌套病例对照研究。使用酶联免疫吸附测定法测量血浆 MBL 水平。使用逻辑回归模型估计血浆 MBL 水平四分位数与 VTE 之间的比值比(OR)。

结果

与 MBL 水平最高四分位数(≥2423ng/ml)相比,血浆 MBL 水平最低四分位数(<435ng/ml)的受试者总体 VTE(OR 0.79,95%置信区间[CI]:0.56-1.10)和 DVT(OR 0.70,95%CI:0.47-1.04)的 OR 降低。经过多变量调整后,对于 VTE、DVT 和肺栓塞(PE),随着采血与 VTE 事件之间的时间间隔缩短,OR 显著降低。

结论

我们的研究结果表明,低血浆 MBL 水平与 VTE 风险降低相关,尤其是 DVT。

相似文献

1
Plasma levels of mannose-binding lectin and future risk of venous thromboembolism.甘露糖结合凝集素的血浆水平与静脉血栓栓塞的未来风险。
J Thromb Haemost. 2019 Oct;17(10):1661-1669. doi: 10.1111/jth.14539. Epub 2019 Jul 1.
2
Plasma levels of P-selectin and future risk of incident venous thromboembolism.血浆 P 选择素水平与静脉血栓栓塞事件的未来风险。
J Thromb Haemost. 2023 Sep;21(9):2451-2460. doi: 10.1016/j.jtha.2023.04.038. Epub 2023 May 12.
3
Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism.补体途径活性、甘露糖结合凝集素与特发性静脉血栓栓塞症发生风险的相关性。
Thromb Res. 2018 Sep;169:50-56. doi: 10.1016/j.thromres.2018.06.019. Epub 2018 Jun 30.
4
High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism.补体激活酶 MASP-2 水平升高与未来静脉血栓栓塞事件风险相关。
Arterioscler Thromb Vasc Biol. 2022 Sep;42(9):1186-1197. doi: 10.1161/ATVBAHA.122.317746. Epub 2022 Jul 21.
5
D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.D-二聚体在静脉血栓诊断中与复发风险相关。
J Thromb Haemost. 2017 May;15(5):917-924. doi: 10.1111/jth.13648. Epub 2017 Feb 24.
6
A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019.一项关于 2019 年冠状病毒病住院患者静脉血栓栓塞症发生率、预后和实验室指标的系统评价和荟萃分析。
J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1099-1111.e6. doi: 10.1016/j.jvsv.2021.01.012. Epub 2021 Jan 30.
7
Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism.通过血浆末端补体复合物评估补体激活与静脉血栓栓塞的未来风险。
J Thromb Haemost. 2019 Jun;17(6):934-943. doi: 10.1111/jth.14438. Epub 2019 May 13.
8
Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.心房颤动与静脉血栓栓塞的未来风险:特罗姆瑟研究。
J Thromb Haemost. 2015 Jan;13(1):10-6. doi: 10.1111/jth.12762. Epub 2014 Nov 22.
9
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.活动性癌症患者首次及复发性静脉血栓栓塞的流行病学。一项基于人群的队列研究。
Thromb Haemost. 2017 Jan 5;117(1):57-65. doi: 10.1160/TH15-08-0686. Epub 2016 Oct 6.
10
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.轻度抗凝血酶缺乏与复发性静脉血栓栓塞风险:来自 MEGA 随访研究的结果。
J Thromb Haemost. 2018 Apr;16(4):680-688. doi: 10.1111/jth.13960. Epub 2018 Feb 28.

引用本文的文献

1
The risk for psychiatric disorders in offspring from thrombosis-prone pedigrees in Sweden: a nationwide family study.瑞典血栓形成倾向家系后代患精神疾病的风险:一项全国性家庭研究。
Res Pract Thromb Haemost. 2025 Jan 28;9(1):102692. doi: 10.1016/j.rpth.2025.102692. eCollection 2025 Jan.
2
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.补体系统凝集素途径的激活、调控、疾病关联及与其他(蛋白水解)系统的相互作用。
Int J Mol Sci. 2024 Jan 26;25(3):1566. doi: 10.3390/ijms25031566.
3
Galectin-3-binding protein and future venous thromboembolism.
半乳糖凝集素-3结合蛋白与未来静脉血栓栓塞症
Res Pract Thromb Haemost. 2024 Jan 3;8(1):102311. doi: 10.1016/j.rpth.2023.102311. eCollection 2024 Jan.
4
Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury.创伤性脑损伤后的神经炎症治疗:补体抑制作为二次损伤的治疗方法。
Neurotherapeutics. 2023 Jan;20(1):284-303. doi: 10.1007/s13311-022-01306-8. Epub 2022 Oct 12.
5
Coagulation and complement: Key innate defense participants in a seamless web.凝血与补体:无缝网络中的固有防御关键参与者。
Front Immunol. 2022 Aug 9;13:918775. doi: 10.3389/fimmu.2022.918775. eCollection 2022.
6
Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.血浆纤溶酶原激活物抑制剂-1 水平升高与未来发生静脉血栓栓塞的风险相关。
J Thromb Haemost. 2022 Jul;20(7):1618-1626. doi: 10.1111/jth.15701. Epub 2022 Mar 25.
7
Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients.甘露糖结合凝集素与危重症 COVID-19 患者的血栓形成和凝血病有关。
Thromb Haemost. 2020 Dec;120(12):1720-1724. doi: 10.1055/s-0040-1715835. Epub 2020 Sep 1.